Sharemaestro Newsreel

Atricure (ATRC) Receives a Buy from Stifel Nicolaus

Stifel Nicolaus analyst Rick Wise maintained a Buy rating on Atricure (ATRC) with a $50.00 price target. This rating comes despite negative corporate insider sentiment and follows Atricure's latest earnings report showing increased revenue year-over-year. Another analyst from Piper Sandler also issued a Buy …

West Pharmaceutical Services, Inc. Revenue Breakdown – MIL:1WST

West Pharmaceutical Services, Inc. (MIL:1WST) reported a total revenue of 2.62 billion EUR last year. The majority of this revenue, 2.12 billion EUR, came from its Proprietary Products segment, although this was a decrease from the previous year's 2.26 billion EUR. The United States …

NXGL|Nexgel Inc|Price:0.439|Chg%:+0.009

Nexgel Inc (NXGL) is trading at $0.439, up 2.09%, with a market capitalization of $3.57 million. The company, which specializes in hydrogel products for healthcare and consumer applications, has strong fundamentals, high growth potential, and institutional buying activity, although its stock performance has been …

Microbot Medical Inc. Revenue Breakdown – NASDAQ:MBOT

This article provides a detailed financial overview of Microbot Medical Inc. (NASDAQ: MBOT), focusing on its revenue breakdown. It highlights the company's financial data, including statements, statistics, dividends, earnings, segments, and performance by source and country, all accessible through TradingView.

PDEX|Pro-Dex Inc|Price:54.930|Chg%:+0.260

Pro-Dex Inc. (PDEX) is trading at $54.930, up 0.48%, with a market capitalization of $175.38 million. The company, which specializes in surgical drivers and air motors, shows strong fundamentals including consistent revenue growth and high profit growth, despite recent institutional selling. Analysts currently rate …

ETFs Investing in Avantor, Inc. Stocks

This article provides a list of Exchange Traded Funds (ETFs) that hold Avantor, Inc. (A2PJN6) stocks, sorted by market value. It details various passive and active ETFs from issuers like BlackRock, Vanguard, and State Street Corp., noting their management style, expense ratio, AUM, price, …

DXR|Daxor Corp|Price:10.450|Chg%:+0.340

Daxor Corp (DXR) is currently trading at $10.45, up 3.27% on the day, with a market capitalization of $61.01M. Analysts have a "Buy" rating for DXR with a target price of $22.50, representing a significant upside. The company specializes in blood volume measurement technology, …

HBIO|Harvard Bioscience Inc|Price:6.000|Chg%:-0.190

Harvard Bioscience Inc. (HBIO) closed at $6.00, down 3.07% on July 24th. The company, which specializes in life science technologies, is considered fairly valued with strong fundamentals and high growth potential. Analysts rate HBIO as a "Buy" with a target price of $6.00, and …

West Pharmaceutical Services, Inc. $WST Shares Sold by KBC Group NV

KBC Group NV reduced its stake in West Pharmaceutical Services (NYSE:WST) by 55.1% in the first quarter, selling over 11,000 shares. This comes as West Pharmaceutical Services reported a strong second quarter, exceeding revenue and EPS estimates, and raising its full-year guidance. Analysts maintain …

Is Intuitive’s AI-Driven Strategy and ESOP Shelf Registration Altering The Investment Case For Intuitive Surgical (ISRG)?

Intuitive Surgical recently filed a US$1.77 billion shelf registration for ESOP-linked shares and reported strong Q2 2026 revenues and net income. Concurrently, the company unveiled a five-layer AI framework and live telesurgical collaboration, indicating a move to integrate AI across its robotic ecosystem. These …

Microbot Medical Inc (MBOT) Earnings Date & Reports & Earnings News

Dimensional Fund Advisors LP Acquires 203,672 Shares of AptarGroup, Inc. $ATR

Dimensional Fund Advisors LP significantly increased its stake in AptarGroup, Inc. by purchasing an additional 203,672 shares, bringing its total holding to over 1.5 million shares valued at approximately $189.6 million. This increase occurred in the first quarter, following AptarGroup's strong quarterly earnings report …

Bank of New York Mellon Corp Reduces Holdings in Baxter International Inc. $BAX

Bank of New York Mellon Corp decreased its stake in Baxter International Inc. by 13.1% in the first quarter, selling 396,247 shares and now owning 2,623,255 shares worth $44.07 million. Other institutional investors had mixed activity, with some increasing their holdings significantly. Analysts have …

BioLife Solutions (NASDAQ:BLFS) Stock Rating Lowered by Wall Street Zen

Azenta, Inc. Revenue Breakdown – NASDAQ:AZTA

Azenta, Inc. (NASDAQ: AZTA) generated $593.82 million in revenue last year. The Sample Management Solutions segment was the top performer, contributing $324.59 million. The United States was the greatest regional contributor, accounting for $365.00 million.

Utah Medical Products (UTMD) Stock Margins Slip To 29% Net Profit Challenging Bullish Narratives

Utah Medical Products (UTMD) reported Q2 2026 revenues of $8.5 million and EPS of $0.84, with a trailing 12-month net profit margin of 29%, down from 32.3% previously. The company faces a 5.8% average annual earnings decline over five years, which challenges bullish narratives …

Intuitive Surgical, Inc. Revenue Breakdown – TURQUOISE:ISRGN

Intuitive Surgical, Inc. (ISRGN) reported total revenue of $10.06 billion, with its Instruments and Accessories segment contributing the most at $6.02 billion. The United States was the largest regional contributor, accounting for $6.82 billion of the company's revenue. These figures highlight the company's key …

ResMed Inc. Revenue Breakdown – NYSE:RMD

AngioDynamics (NASDAQ: ANGO) CEO settles performance share grant

AngioDynamics (NASDAQ: ANGO) CEO James C. Clemmer settled a performance share grant from 2023, receiving 52,358 shares of Common Stock. The original grant of 184,361 units was based on multi-year performance metrics, with the remaining units forfeited. To cover tax withholding obligations, 26,728 shares …

AngioDynamics Inc (ANGO) CFO performance shares vest, tax withheld

AngioDynamics Inc. CFO Stephen A. Trowbridge received 16,296 shares of common stock from the vesting of performance share units, which were part of a target grant of 57,381 units on July 19, 2023. The shares vested based on performance metrics and relative total shareholder …

Innovative Eyewear, Inc. Revenue Breakdown – NASDAQ:LUCY

Innovative Eyewear, Inc. (NASDAQ: LUCY) generated $2.66 million USD in revenue last year, with its e-commerce segment contributing the most at $2.43 million USD. All of the company's revenue originated from the United States, which saw a slight increase from $1.64 million USD the …

Intuitive Surgical, Inc. Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next

Intuitive Surgical, Inc. recently reported earnings that surpassed analyst expectations, driven by higher revenue and earnings per share. Following these strong results, analysts have revised their price targets and earnings estimates upwards, indicating a positive outlook for the company's future performance. The general sentiment …

Did You Lose Money on Embecta Corp. (EMBC)? Levi & Korsinsky Urges Investors to Act Before August 17, 2026

Levi & Korsinsky, LLP has filed a securities class action lawsuit against Embecta Corp. (NASDAQ:EMBC) on behalf of investors who suffered losses due to alleged securities fraud between November 25, 2025, and May 4, 2026. The lawsuit claims Embecta made misleading statements regarding its …

ICU Medical, Inc. Revenue Breakdown – TRADEGATE:IC7

ICU Medical, Inc. (TRADEGATE:IC7) generated 1.88 billion EUR in revenue last year, with its Consumables segment being the top performer, contributing 944.33 million EUR. The United States was the largest geographical contributor, accounting for 1.15 billion EUR of the company's revenue. The article provides …

West Pharmaceutical Services (WST) Stock Sees Margin Improvement Narrative Backed By Q2 2026 Results

West Pharmaceutical Services (WST) reported a strong Q2 2026 with increased revenue and basic EPS, demonstrating improved profitability with a trailing twelve-month net profit margin of 17%. The company's margin strength is attributed to higher-margin High Value Product components and GLP-1 related products, which …

Repligen Corp|Price:131.970|Chg%:-5.630

This article provides a company profile for Repligen Corporation (RGEN), a global life sciences company specializing in bioprocessing technologies. It details the company's focus areas, product portfolio, and key financial information. The article also lists company executives, their shareholdings, and institutional ownership data for …

Sanara Medtech Inc (SMTI) Financial Health: Profitability & Balance Sheet Analysis

Sanara Medtech Inc (SMTI) currently holds a financial score of 7.31, ranking 117 out of 155 in the pharmaceuticals industry, indicating stable financial health and high operating efficiency. The company reported a significant year-over-year revenue increase of 18.62% to $27.80 million, and its net …

Repligen Corp (RGEN) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution

This article provides a detailed revenue breakdown for Repligen Corp (RGEN) by business segment and by region. For FY2025, filtration products were the largest segment, contributing 54.58% of revenue, while North America was the largest regional market at 49.00%. The data highlights the company's …

AtriCure (ATRC) Stock Faces Mixed Views As EPS Turnaround Tests Margin Narratives

AtriCure (ATRC) reported strong Q2 2026 results with a significant EPS turnaround and increased revenue, driven by improved margins and operating leverage rather than just revenue growth. While the profitability improvement supports bullish sentiment, the widely divergent valuation metrics (low DCF fair value vs. …

Icu Medical (ICUI) Q1 2024 Earnings Report - Results, Call & Slides

ICU Medical (ICUI) reported its Q1 2024 earnings, beating analyst expectations with an actual EPS of $0.96 against a consensus of $0.82 and revenue of $565.96 million compared to an expected $552.25 million. Despite beating estimates, the company's EPS saw a year-over-year decrease from …

NVST|Envista Holdings Corp|Price:26.330|Chg%:+0.140

Envista Holdings Corp (NVST) shows strong fundamentals and high growth potential, despite trading sideways. The company is considered fairly valued within the Healthcare Equipment & Supplies industry and has high institutional ownership. Analysts have a positive outlook, with a 'Buy' rating and a target …

OraSure Technologies, Inc. Revenue Breakdown – LSX:881351

OraSure Technologies, Inc. (LSX:881351) generated 97.93 million EUR in revenue last year, with its Human Immunodeficiency Virus segment contributing the most at 42.40 million EUR. The United States was the largest regional contributor, accounting for 66.63 million EUR of the company's revenue.

EMBC|Embecta Corp|Price:3.295|Chg%:+0.045

Embecta Corp (EMBC) is a global medical device company focusing on diabetes care, offering a portfolio of pen needles, syringes, and safety injection devices. The company's executives and their shareholdings are detailed, with Mr. Devdatt Kurdikar serving as Chairman, President, and CEO. Institutional ownership …

Solventum Corp (SOLV) Technical Analysis: Support, Resistance, Indicators & Moving Averages

This article provides a technical analysis of Solventum Corp (SOLV), detailing its current price momentum score, support and resistance levels, and insights from various technical indicators and moving averages. According to the analysis, SOLV's price is currently suitable for range-bound swing trading, with a …

AngioDynamics (ANGO) SVP receives shares from PSU vesting, with tax withholding

Chad Thomas Campbell, SVP/GM Vascular Access at AngioDynamics (ANGO), received 6,466 shares of common stock from the vesting of performance share units, which were originally granted on July 19, 2023. To cover tax withholding obligations, 2,330 shares were disposed of at $13.82 per share. …

Microbot Medical (MBOT) Short Interest & Short Float | Updated Jul 2026

Microbot Medical (MBOT) currently has 7.49 million shares sold short as of July 15, 2026, representing 11.71% of its public float, which is a 1.92% increase from the prior report. The short interest ratio stands at 10.9 days to cover, indicating a significant level …